CRACR2A was also required to support migration of MDA-MB-231 breast cancer cells (which lack Rab25 expression, but express high levels of CRACR2A) in the 3D CDM (Fig. 8C; Fig. S8C). This evidence concerns the gene CRACR2A and breast carcinoma.